L282-0729 Screening compound: 3-(3-chlorophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

L282-0729 Screening compound: 3-(3-chlorophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea
L282-0729 Screening compound: 3-(3-chlorophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea alternative view

Chemical Structure Depiction of ChemDiv screening compound L282-0729
3-(3-chlorophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L282-0729

Molecular Formula

C21H19ClN6OS (C21 H19 ClN6 OS)

Compound Name

3-(3-chlorophenyl)-1-[4-({5-ethyl-2-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

IUPAC name

3-(3-chlorophenyl)-1-[4-({5-ethyl-2-methyl-[124]triazolo[15-a]pyrimidin-7-yl}sulfanyl)phenyl]urea

SMILES

CCc1nc2nc(C)nn2c(Sc(cc2)ccc2NC(Nc2cccc(Cl)c2)=O)c1

InChI

InChI=1S/C21H19ClN6OS/c1-3-15-12-19(28-20(24-15)23-13(2)27-28)30-18-9-7-16(8-10-18)25-21(29)26-17-6-4-5-14(22)11-17/h4-12H,3H2,1-2H3,(H2,25,26,29)

InChI Key

WHUHBFIZMKMMOI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27239699

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.94

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.662

Distribution Coefficient, logD

5.662

Water Solubility, LogSw

-5.79

Polar Surface Area

63.413

Acid Dissociation Constant (pKa)

11.75

Base Dissociation Constant (pKb)

3.68

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

L282-0729 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Proteases
  • Phosphatases

References: we are preparing a list of scientific research reports with L282-0729 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L282-0729?
Check Price and Availability of L282-0729, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L282-0729 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L282-0729
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L282-0729
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L282-0729 available by request